Validation of Skin Field Cancerisation Index: the assessment of a solar damage severity tool for patients undergoing radiotherapy treatment for field cancerisation.

Not Applicable

• Conditions: Skin Cancer including Keratinocyte Carcinomas; Skin - Dermatological conditions; Cancer - Malignant melanoma; Cancer - Non melanoma skin cancer

• Registration Number: ACTRN12620000056998
• Lead Sponsor: GenesisCare

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-01-23
• Last Update Posted: 3 February 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

1. Treatable region of Skin Field Cancerisation in at least one of the following regional areas:
o Scalp
o Forehead
o Nose
o Cheek (one)
o Ear (one)
o Forearm (one)
o Back of Hand (one)
o Lower leg (one)
o Top of foot (one)
o Chest (Decolletage)
o Torso (or front or back)

2. De-identified - Photographs of participants over 18 years of age. Photographs will be collected only from two sites from patients who attended clinics .These two sites are QIDerm in Brisbane and St Vincent's Hospital in Melbourne.

The images will have sufficient protection to protect patient privacy. Only areas that are considered inherently non-identifiable i.e., forearms, lower legs, chest and scalp are included. Any other sites will have blackouts of the eyes and other identifying features. All photos will be de-identified before being added to the study and there will be no photos with identifying tattoos or distinctive markings. This process is being used to protect the privacy of the participants and for the fact that identifiable markings will interfere with the scoring system. De-identified photography will be used in the study in accordance with the Australian Privacy Principals Guidelines Act 1988. All imaging will remove eye features and other distinguishing skin markings that could be used to identify participants. Imaging is part of standard clinical care and consent for taking these images is part of the general dermatologist’s practice consent process (Please see consent forms for the QIDerm and Dr Baker’s practice)

Exclusion Criteria

Poor quality photographs;
• Other dermatoses effecting assessment (e.g. inflammatory
skin diseases) that may confuse scorers.

Study & Design

• Study Type: Observational
• Study Design: Not specified